Recorded Presentations from the NCCN 7th Annual Congress: Hematologic Malignancies™

Treatment of hematologic malignancies is increasingly complex. Issues relating to pathology, transplantation, and various new therapies require oncologists and hematologists to stay abreast of breakthrough advances. In addition, targeted therapies and oral treatments bring the latest benefits to patients. This Congress focuses on the new approaches that have been incorporated into patient management, including the use of drugs, biologics, and diagnostics.

Fee Information:
There is no fee for these educational activities.

Accreditation:
These activities are approved for AMA PRA Category 1 Credit(s)™. Nursing and pharmacy (ACPE) credits are also provided. Complete accreditation details are provided at the beginning of the individual activities.

Supporters:
Supported by educational grants from Genentech; Millennium: The Takeda Oncology Company; Novartis Pharmaceuticals Corporation; Otsuka America Pharmaceutical, Inc.; and sanofi-aventis U.S.

Check the boxes next to the activities you would like to complete and click "Sign up for selected activities."
Then, click the title of the activity and the green Take Course button to proceed.